BARCLAYS PLC

Position in IBIO — iBio, Inc.

CIK 312069 LONDON, X0

Position in IBIO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$5,696

+$5,693 QoQ

Shares Held

3,255

+162650.0% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#41

of 55 holders

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. IBIO ranks #338 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	733,274	$364,239,192
2	REGN	Regeneron Pharmaceuticals, Inc.	256,192	$159,745,957
3	IONS	Ionis Pharmaceuticals Inc	1,603,136	$127,112,653
4	ARGX	Argenx SE	134,427	$124,717,337
5	MRNA	Moderna, Inc.	1,035,126	$72,489,872
6	BBIO	BridgeBio Pharma, Inc.	714,423	$53,210,224
7	TGTX	Tg Therapeutics, Inc.	957,848	$52,624,168
8	DNTH	Dianthus Therapeutics, Inc. /DE/	431,753	$42,087,281

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,696	3,255	+162650.0%	Shares	Defined	2026-08-14
2025-12-31	$3	2	-97.6%	Shares	Defined	2026-02-13
2025-03-31	$329	82	-99.8%	Shares	Sole	2026-03-17
2022-03-31	$15,085	35,082	-86.6%	Shares	Sole	2022-05-16
2021-12-31	$144,272	262,314	+197.0%	Shares	Sole	2022-02-14
2021-09-30	$93,617	88,318	-13.1%	Shares	Sole	2021-11-09
2021-06-30	$153,415	101,600	-59.9%	Shares	Sole	2021-08-13
2021-03-31	$389,941	253,209	+335.4%	Shares	Sole	2021-05-13
2020-12-31	$61,061	58,154	+0.4%	Shares	Sole	2021-02-11
2020-09-30	$117,555	57,909	+26.0%	Shares	Sole	2020-11-12
2020-06-30	$102,024	45,957	—	Shares	Sole	2020-08-12
No filing history on record for this holder in this stock.